Articles related to VIRUSES

New research suggests that the COVID-19 virus and its remnant spike protein may bind to and kill lymphocytes, leading to lymphopenia.

The potential of the antiviral combo in reducing the risk of thromboembolic events among post-COVID-19 patients is real. Could it pave the way for more targeted therapeutic strategies in managing post-COVID-19 conditions?

Stay informed about the latest advancements in immunization practices. Learn more about the new FDA-approved RSV vaccines and their potential impact on patient care.

ACIP’s endorsement of Abrysvo offers a new preventive measure against RSV in infants, urging healthcare providers to discuss this option with expectant parents.

Stay ahead of the curve with the latest updates from the CDC and ACP on COVID-19 vaccinations and outpatient treatments, designed to prepare healthcare settings for the upcoming fall and winter season.

Learn how the termination of USAID’s DEEP VZN program could signal a shift in global health priorities, emphasizing the importance of disease surveillance and biosecurity over speculative virus hunting.